Evidence map›Paper›PMID 39955775›Full record

ArticleCell reports2025

TGF-β1-mediated intercellular signaling fuels cooperative cellular invasion.

Tala O Khatib, Brian A Pedro, Sergei Bombin, Veronika Y Matsuk, Isaac E Robinson, Sarah F Webster, Landon J Marcus, Emily R Summerbell, Gregory K Tharp, Christina M Knippler and 7 more

Abstract read
In one paragraph

Article in Cell reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tala O KhatibDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA.
Brian A PedroDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Sergei BombinWinship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Emory Integrated Computational Core, Emory University, Atlanta, GA 30322, USA.
Veronika Y MatsukDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Isaac E RobinsonDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
Sarah F WebsterDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Landon J MarcusCommunity Scientist, Atlanta, GA 30033, USA.
Emily R SummerbellOffice of Intramural Training and Education, The National Institutes of Health, Bethesda, MD 20892, USA.
Gregory K TharpEPC Genomics Core, Emory University, Atlanta, GA 30322, USA.
Christina M KnipplerWinship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Pritha BagchiEmory Integrated Proteomics Core, Emory University, Atlanta, GA 30322, USA.
Jeanne Kowalski-MueggeDell Medical School, University of Texas at Austin, Austin, TX 78712, USA.
H Rich JohnstonWinship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Emory Integrated Computational Core, Emory University, Atlanta, GA 30322, USA.
Homa GhaleiGraduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Paula M VertinoJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Janna K MouwDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA. Electronic address: jmouw@emory.edu.
Adam I MarcusDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA. Electronic address: aimarcu@emory.edu.

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Ragini Reiney Kudchadkar · 2009 to 2026
$47.5M
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinomaP01CA257906 · NCI · EMORY UNIVERSITY · PI Yuan Liu · 2022 to 2026
$10.7M
Spatiotemporal interrogation of metabolic cooperation between heterogenous lung cancer subpopulations in collective cell invasionR01CA247367 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I., SHANMUGAM, MALATHY (MALA) · 2021 to 2025
$2.3M
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell InvasionR01CA250531 · NCI · UNIVERSITY OF ROCHESTER · PI VERTINO, PAULA M. · 2021 to 2025
$2.2M
Atypical Angiogenic Mimicry During Collective Lung Cancer InvasionR01CA236369 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2019 to 2023
$1.8M
Deconstructing the collective invasion pack to define Myo10 functionR01CA250422 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2020 to 2024
$1.8M
Deconstructing cellular heterogeneity and subpopulation cooperation in non-small cell lung cancer metastasisR50CA265345 · NCI · EMORY UNIVERSITY · PI MOUW, JANNA K · 2021 to 2025
$720k
NCATS NIH HHS UL1 TR002378NCI NIH HHS P01 CA257906NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA236369NCI NIH HHS R01 CA247367NCI NIH HHS R01 CA250422NCI NIH HHS R01 CA250531NCI NIH HHS R50 CA265345
6 · The paper itself

Abstract

Intratumoral heterogeneity drives cancer progression and influences treatment outcomes. The mechanisms underlying how cellular subpopulations communicate and cooperate to impact progression remain largely unknown. Here, we use collective invasion as a model to deconstruct processes underlying non-small cell lung cancer subpopulation cooperation. We reveal that collectively invading packs consist of heterogeneously cycling and non-cycling subpopulations using distinct pathways. We demonstrate that the follower subpopulation secretes transforming growth factor beta one (TGF-β1) to stimulate divergent subpopulation responses-including proliferation, pack cohesion, and JAG1-dependent invasion-depending on cellular context. While isolated followers maintain proliferation in response to TGF-β1, isolated leaders enter a quiescence-like cellular state. In contrast, leaders within a heterogeneous population sustain proliferation to maintain subpopulation proportions. In vivo, both leader and follower subpopulations are necessary for macro-metastatic disease progression. Taken together, these findings highlight that intercellular communication preserves tumor cell heterogeneity and promotes collective behaviors such as invasion and tumor progression.

Indexed as

Carcinoma, Non-Small-Cell LungCell CommunicationLung NeoplasmsSignal TransductionTransforming Growth Factor beta1AnimalsCell Line, TumorCell MovementCell ProliferationHumansJagged-1 ProteinMiceNeoplasm InvasivenessJagged-1 ProteinTransforming Growth Factor beta1cell cycle progressioncollective invasionCP: Cancerheterogeneityintercellular cooperationtumor progression

Identifiers

PMID39955775
PMCPMC11951108

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.